Cargando…

Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function

Phosphoinositide 3-kinases (PI3Ks) are promising targets for therapeutic development in cancer. The class I PI3K isoform p110α has received considerable attention in oncology because the gene encoding p110α (PIK3CA) is frequently mutated in human cancer. However, little is known about the function o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yea, Sung Su, So, Lomon, Mallya, Sharmila, Lee, Jongdae, Rajasekaran, Kamalakannan, Malarkannan, Subramaniam, Fruman, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051752/ https://www.ncbi.nlm.nih.gov/pubmed/24915189 http://dx.doi.org/10.1371/journal.pone.0099486

Ejemplares similares

Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation
por: Palmer, Jeanne M, et al.
Publicado: (2012)

Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1
por: Mallya, Sharmila, et al.
Publicado: (2014)

Transcriptional Regulation of Natural Killer Cell Development and Functions
por: Wang, Dandan, et al.
Publicado: (2020)

Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8(+) T Cells
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2010)

Natural Killer Cells: Development, Maturation, and Clinical Utilization
por: Abel, Alex M., et al.
Publicado: (2018)

IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration
por: Kumar, Pawan, et al.
Publicado: (2012)

IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection
por: Kumar, Pawan, et al.
Publicado: (2019)

267 Defining the single-cell transcriptomes of splenic adaptive Natural Killer cells in donors with latent human cytomegalovirus infection
por: Khalil, Mohamed, et al.
Publicado: (2023)

mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells
por: Beagle, Brandon R., et al.
Publicado: (2014)

Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency
por: Mace, Emily M.
Publicado: (2018)

Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation
por: Pritchard, Rory A., et al.
Publicado: (2016)

Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2016)

mTORC1 and mTORC2 differentially promote natural killer cell development
por: Yang, Chao, et al.
Publicado: (2018)

The Fyn–ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer Cells
por: Gerbec, Zachary J., et al.
Publicado: (2015)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023)

Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
por: Shey, Susan, et al.
Publicado: (2021)

RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
por: Fritsch, Ralph, et al.
Publicado: (2013)

The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation
por: Chiu, Honyin, et al.
Publicado: (2017)

Fyn-ADAP signaling via Carma1-Bcl10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2013)

Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes
por: Awasthi, Aradhana, et al.
Publicado: (2010)

Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors
por: Mannella, Viviana, et al.
Publicado: (2021)

Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008)

Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)

Full Activation of Kinase Protein Kinase B by Phosphoinositide-Dependent Protein Kinase-1 and Mammalian Target of Rapamycin Complex 2 Is Required for Early Natural Killer Cell Development and Survival
por: He, Junming, et al.
Publicado: (2021)

Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
por: Vo, Thanh-Trang, et al.
Publicado: (2021)

Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence
por: Bloomfield, Marketa, et al.
Publicado: (2021)

The Phosphoinositide 3-Kinase Isoform PI3Kβ Regulates Osteoclast-Mediated Bone Resorption in Humans and Mice
por: Győri, Dávid, et al.
Publicado: (2014)

Expression of Phosphoinositide-Specific Phospholipase C Isoforms in Native Endothelial Cells
por: Béziau, Delphine M., et al.
Publicado: (2015)

Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling
por: Maffucci, Tania, et al.
Publicado: (2020)

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
por: Park, Jeong Su, et al.
Publicado: (2020)

Involvement of Class II Phosphoinositide 3-Kinase α-Isoform in Antigen-Induced Degranulation in RBL-2H3 Cells
por: Nigorikawa, Kiyomi, et al.
Publicado: (2014)

Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
por: Yang, Chao, et al.
Publicado: (2019)

Phosphoinositide-3-Kinase Is the Primary Mediator of Phosphoinositide-Dependent Inhibition in Mammalian Olfactory Receptor Neurons
por: Ukhanov, Kirill, et al.
Publicado: (2016)

The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes
por: Azzi, Jamil, et al.
Publicado: (2012)

Initiation of human astrovirus type 1 infection was blocked by inhibitors of phosphoinositide 3-kinase
por: Tange, Shoichiro, et al.
Publicado: (2013)

Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells
por: Bozorg-Ghalati, Farzaneh, et al.
Publicado: (2017)

Sodium-Glucose Cotransporter-2 Inhibitors for Hyperglycemia in Phosphoinositide 3-kinase Pathway Inhibition
por: Weintraub, Michael A, et al.
Publicado: (2023)

Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
por: Huw, L-Y, et al.
Publicado: (2013)

Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function
por: Chiu, Honyin, et al.
Publicado: (2021)

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity
por: Krzywinska, Ewelina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tadbpvifhv279lu7sto0flsauu